Results 11 to 20 of about 54,693 (255)

Humoral and Cellular Immunity to Severe Acute Respiratory Syndrome Coronavirus-2 Vaccination in Patients with Sarcoidosis

open access: yesBalkan Medical Journal, 2023
Background: The coronavirus disease 2019 vaccine induces both antibody and T-cell immune responses and has been proven to be effective in preventing coronavirus disease 2019, including its severe disease form, in healthy individuals. However, the details
Ersan Atahan   +4 more
doaj   +1 more source

Screening for Latent Tuberculosis Infection using Interferon-Gamma Release Assay Test among Healthcare Workers

open access: yesGlobal Medical & Health Communication, 2023
Healthcare workers (HCWs) represent a significant demographic for screening latent tuberculosis infection (LTBI) due to their potential exposure to infectious patients.
Rosamarlina Rosamarlina   +8 more
doaj   +1 more source

Interferon gamma release assay in the diagnosis of tuberculous mastitis [PDF]

open access: yesThe Annals of The Royal College of Surgeons of England, 2015
Tuberculous mastitis is rare, especially in Western countries. We describe a case where the interferon gamma release assay blood test led to diagnosis and successful treatment of the disease.
H L, Robbins   +3 more
openaire   +2 more sources

Interferon-Gamma Release Assay Improves the Diagnosis of Tuberculosis in Children [PDF]

open access: yesPediatric Infectious Disease Journal, 2009
Interferon-gamma release assays (IGRAs) have been recently developed for the diagnosis of tuberculosis (TB) infection. The aim of the present study was to evaluate the performance of an enzyme-linked immunosorbent assay (ELISA)-based IGRA for detecting TB in children.A prospective study in 336 children at risk for TB infection was carried out.
Bianchi L.   +7 more
openaire   +2 more sources

Performance evaluation of newly developed fluorescence immunoassay-based interferon-gamma release assay for the diagnosis of latent tuberculosis infection in healthcare workers

open access: yesJournal of Microbiology, Immunology and Infection, 2022
The ichroma™ IGRA-TB (Boditech Med Inc., Chuncheon, Republic of Korea) is an automated fluorescent immunoassay-based point-of-care interferon-gamma release assay for detecting latent tuberculosis infection.
Oh Joo Kweon   +4 more
doaj   +1 more source

Role of interferon gamma release assay in the diagnosis and management of Mycobacterium tuberculosis-associated uveitis: a review

open access: yesBMJ Open Ophthalmology, 2021
Tuberculosis (TB)-associated uveitis is a common cause of infectious uveitis in the developing world. Diagnosis of TB uveitis remains a challenge. The role of interferon gamma release assays (IGRAs) is uncertain.
M A Rehman Siddiqui   +2 more
doaj   +1 more source

«Interferon Gamma Release Assays» ou IGRA

open access: yesForum Médical Suisse ‒ Swiss Medical Forum, 2021
Bei IGRA handelt es sich um In-vitro-Tests zum Nachweis von spezifischen Effektor-T-Lymphozyten, die nach Sensibilisierung durch Mycobacterium tuberculosis Interferon gamma produzieren.
Minh Khoa Truong   +4 more
openaire   +1 more source

Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting

open access: yesMultiple Sclerosis Journal - Experimental, Translational and Clinical, 2019
Background Tuberculosis screening is recommended in multiple sclerosis patients starting certain disease-modifying therapies. Disease-modifying therapies may affect interferon-gamma release assay results.
Laura E Baldassari   +7 more
doaj   +1 more source

Tuberculosis infection risk, preventive therapy care cascade and incidence of tuberculosis disease in healthcare workers at Maputo Central Hospital

open access: yesBMC Infectious Diseases, 2019
Background Mozambican healthcare workers have high rates of latent and active tuberculosis, but occupational screening for tuberculosis is not routine in this setting.
Susannah K. Graves   +13 more
doaj   +1 more source

INTERFERON GAMMA RELEASE ASSAY AMONG TUBERCULOSIS CULTURE POSITIVE AND NEGATIVE CASES TO DETERMINE CUT OFF VALUE

open access: yesPakistan Armed Forces Medical Journal, 2019
Objective: To determine cut off value of Interferon Gamma Release Assay (IGRA) among Tuberculosis (TB) suspected patients and to compare median Interferon Gamma Release Assay value for Tuberculosis culture positive and culture negative patients. Study
Nauman Akbar   +5 more
doaj   +4 more sources

Home - About - Disclaimer - Privacy